← Back to Search

Procedure

RCT vs Pulpotomy for Toothache

N/A
Waitlist Available
Led By Ashraf Fouad, DDS
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Maxillary or mandibular first or second mature permanent molars with carious lesions or restorations (excluding crowns), with signs and symptoms of reversible or irreversible pulpitis, requiring treatment, where pulp exposure is detectable upon excavation
Patients aged ≥10y for first molars and ≥16y for second molars
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 2 years
Awards & highlights

Study Summary

This trial is testing different ways to treat a tooth with a cavity that has reached the nerve (pulp). The goal is to find the best way to treat this type of Cavity so that the tooth doesn't need to be removed.

Who is the study for?
This trial is for people with a toothache from a mature permanent molar that's still alive and has caries or fillings, but isn't badly broken or unrestorable. Participants should be over 10 years old for first molars and over 16 for second molars. They can't join if they have certain dental conditions, are on specific medications, pregnant, or need sedation/general anesthesia.Check my eligibility
What is being tested?
The study is testing two treatments to manage irreversible pulpitis in teeth: pulpotomy (removing the diseased part of the pulp) versus root canal therapy (RCT). It aims to find out which treatment works best and what signs predict successful vital pulp therapy.See study design
What are the potential side effects?
Possible side effects include discomfort at the site of treatment, infection risk due to exposure during procedures, temporary sensitivity or pain post-treatment. In some cases where treatment fails, additional interventions like RCT may be necessary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a deep cavity or filling in my molar that may have reached the nerve, causing pain.
Select...
I am at least 10 years old for first molar treatment and 16 for second.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline through 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline through 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of patients with a successful outcome of pulpotomy versus RCT
Secondary outcome measures
Determine prognostic validity of a set of pulpal inflammatory proteins in determining the outcome of pulpotomy
Determine prognostic validity of preoperative hyperalgesia in determining the outcome of pulpotomy

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PulpotomyExperimental Treatment1 Intervention
Pulpotomy with tricalcium silicates has shown high clinical success in these cases. However, it is not known how this success compares to RCT under similar conditions and with an intent-to-treat study design, which will be employed here.
Group II: Root canal treatment (RCT)Active Control1 Intervention
For cases with this diagnosis RCT is the standard of care and will be done according to clinically approved protocols
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pulpotomy
2020
N/A
~350

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,583 Previous Clinical Trials
2,279,906 Total Patients Enrolled
2 Trials studying Toothache
1,000 Patients Enrolled for Toothache
Ashraf Fouad, DDSPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

RCT (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04922229 — N/A
Toothache Research Study Groups: Root canal treatment (RCT), Pulpotomy
Toothache Clinical Trial 2023: RCT Highlights & Side Effects. Trial Name: NCT04922229 — N/A
RCT (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04922229 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there open spots still available in this clinical investigation?

"The information found on clinicaltrials.gov indicates that this medical experiment is not presently taking part in patient recruitment as of now. The study was first launched on December 1st 2023 and last amended February 3rd 2022, though there are currently 21 other studies seeking volunteers at the moment."

Answered by AI

What are the stipulations for participation in this experiment?

"Potential participants for this trial must have pulpitis and range in age from 10 to 99 years. The researchers are actively searching for around 138 enrollees."

Answered by AI

Are individuals over the age of 30 being enrolled in this investigation?

"The requirements for participation in this clinical trial include being aged between 10 to 99 years. For those under 18 or above 65, there are 11 and 8 specific trials respectively."

Answered by AI
~92 spots leftby Dec 2029